WASHINGTON, United States (AFP) — The US Food and Drug Administration (FDA) on Wednesday authorized using a so-called “mix and match” strategy for people who require a booster shot of a Covid vaccine after their primary series. “The FDA has determined that the known and potential benefits of the use of a single heterologous booster dose outweigh the known and potential risks of their use in eligible populations,” the agency said in a statement. The […]